{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:20:25Z","timestamp":1787012425606,"version":"build-2736575974"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T00:00:00Z","timestamp":1486684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"COMET Center ONCOTYROL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s40258-017-0312-3","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T21:09:23Z","timestamp":1486674563000},"page":"333-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review"],"prefix":"10.1007","volume":"15","author":[{"given":"Irmgard C.","family":"Schiller-Fr\u00fchwirth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Arvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"issue":"2","key":"312_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"312_CR2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","volume":"14","author":"R Luengo-Fernandez","year":"2013","unstructured":"Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol. 2013;14(12):1165\u201374.","journal-title":"Lancet Oncol"},{"key":"312_CR3","unstructured":"American Cancer Society, Inc. The global economic cost of cancer. 2010. http:\/\/www.cancer.org\/acs\/groups\/content\/@internationalaffairs\/documents\/document\/acspc-026203.pdf . Accessed 11 Nov 2016."},{"issue":"2","key":"312_CR4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.sembd.2007.09.007","volume":"10","author":"CN Klabunde","year":"2007","unstructured":"Klabunde CN, Ballard-Barbash R. Evaluating population-based screening mammography programs internationally. Semin Breast Dis. 2007;10(2):102\u20137.","journal-title":"Semin Breast Dis"},{"key":"312_CR5","volume-title":"Breast cancer screening","author":"World Health Organization","year":"2002","unstructured":"World Health Organization. International Agency for Research on Cancer. IARC handbooks of cancer prevention. Vol. 7. In: Vainio H, Bianchini F, editors. Breast cancer screening. IARC Press; Lyon, 2002."},{"issue":"5 Part 1","key":"312_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7326\/0003-4819-137-5_Part_1-200209030-00012","volume":"137","author":"LL Humphrey","year":"2002","unstructured":"Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(5 Part 1):347\u201360.","journal-title":"Ann Intern Med"},{"issue":"7","key":"312_CR7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1445-2197.1995.tb01791.x","volume":"65","author":"JR Butler","year":"1995","unstructured":"Butler JR, Furnival CM, Hart RF. The costs of treating breast cancer in Australia and the implications for breast cancer screening. Aust N Z J Surg. 1995;65(7):485\u201391.","journal-title":"Aust N Z J Surg"},{"issue":"2","key":"312_CR8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00662136","volume":"25","author":"ML Brown","year":"1993","unstructured":"Brown ML, Fintor L. Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res Treat. 1993;25(2):113\u20138.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"312_CR9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S0266462300012253","volume":"14","author":"JL Wolstenholme","year":"1998","unstructured":"Wolstenholme JL, Smith SJ, Whynes DK. The costs of treating breast cancer in the United Kingdom: implications for screening. Int J Technol Assess Health Care. 1998;14(2):277\u201389.","journal-title":"Int J Technol Assess Health Care"},{"issue":"7","key":"312_CR10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/annonc\/mdg280","volume":"14","author":"V Cocquyt","year":"2003","unstructured":"Cocquyt V, Moeremans K, Annemans L, et al. Long-term medical costs of postmenopausal breast cancer therapy. Ann Oncol. 2003;14(7):1057\u201363.","journal-title":"Ann Oncol"},{"issue":"4","key":"312_CR11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1017\/S0266462300007169","volume":"7","author":"A Elixhauser","year":"1991","unstructured":"Elixhauser A. Costs of breast cancer and the cost-effectiveness of breast cancer screening. Int J Technol Health Care. 1991;7(4):604\u201315.","journal-title":"Int J Technol Health Care"},{"issue":"4","key":"312_CR12","first-page":"347","volume":"42","author":"A Rashidian","year":"2013","unstructured":"Rashidian A, Barfar E, Hosseini H, et al. Cost effectiveness of breast cancer screening using mammography; a systematic review. Iran J Public Health. 2013;42(4):347\u201357.","journal-title":"Iran J Public Health"},{"issue":"1","key":"312_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.healthpol.2006.03.006","volume":"80","author":"I Williams","year":"2007","unstructured":"Williams I, Bryan S. Understanding the limited impact of economic evaluation in health care resource allocation: a conceptual framework. Health Policy. 2007;80(1):135\u201343.","journal-title":"Health Policy"},{"issue":"2","key":"312_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1258\/135581907780279521","volume":"12","author":"I Williams","year":"2007","unstructured":"Williams I, Bryan S, McIver S. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach. J Health Serv Res Policy. 2007;12(2):73\u20139.","journal-title":"J Health Serv Res Policy"},{"issue":"4","key":"312_CR15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10198-007-0078-x","volume":"9","author":"X Sun","year":"2008","unstructured":"Sun X, Faunce T. Decision-analytical modelling in health-care economic evaluations. Eur J Health Econ. 2008;9(4):313\u201323.","journal-title":"Eur J Health Econ"},{"key":"312_CR16","unstructured":"Kulasingam SL, Havrilesky L, Ghebre R, Myers ER. U.S. Preventive Services Task Force evidence syntheses, formerly systematic evidence reviews. Screening for cervical cancer: a decision analysis for the US Preventive Services Task Force. Rockville (MD): US Agency for Healthcare Research and Quality; 2011."},{"issue":"9","key":"312_CR17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/0003-4819-149-9-200811040-00244","volume":"149","author":"AG Zauber","year":"2008","unstructured":"Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659\u201369.","journal-title":"Ann Intern Med"},{"key":"312_CR18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.pharmtox.40.1.209","volume":"40","author":"NH Holford","year":"2000","unstructured":"Holford NH, Kimko HC, Monteleone JP, Peck CC. Simulation of clinical trials. Ann Rev Pharmacol Toxicol. 2000;40:209\u201334.","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"312_CR19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10198-003-0205-2","volume":"4","author":"U Siebert","year":"2003","unstructured":"Siebert U. When should decision-analytic modeling be used in the economic evaluation of health care? Eur J Health Econ. 2003;4:143\u201350.","journal-title":"Eur J Health Econ"},{"issue":"13","key":"312_CR20","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.1990.03450130109039","volume":"264","author":"DM Eddy","year":"1990","unstructured":"Eddy DM. Clinical decision making: from theory to practice. Connecting value and costs: whom do we ask, and what do we ask them? JAMA. 1990;264(13):1737\u20139.","journal-title":"JAMA"},{"issue":"10","key":"312_CR21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/0003-4819-139-10-200311180-00011","volume":"139","author":"J Mandelblatt","year":"2003","unstructured":"Mandelblatt J, Saha S, Teutsch S, et al. The cost-effectiveness of screening mammography beyond age 65\u00a0years: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139(10):835\u201342.","journal-title":"Ann Intern Med"},{"issue":"4","key":"312_CR22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.breast.2015.03.013","volume":"24","author":"RG Koleva-Kolarova","year":"2015","unstructured":"Koleva-Kolarova RG, Zhan Z, Greuter MJ, et al. Simulation models in population breast cancer screening: a systematic review. Breast. 2015;24(4):354\u201363.","journal-title":"Breast"},{"issue":"5","key":"312_CR23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/0272989X12454577","volume":"32","author":"JJ Caro","year":"2012","unstructured":"Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices: overview. a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Med Decis Mak. 2012;32(5):667\u201377.","journal-title":"Med Decis Mak"},{"key":"312_CR24","unstructured":"Tufts Medical Center CEA Registry. http:\/\/healtheconomics.tuftsmedicalcenter.org\/cear4\/SearchingtheCEARegistry\/SearchtheCEARegistry.aspx . Accessed 23 Nov 2016."},{"key":"312_CR25","unstructured":"Systematic reviews: CRD\u2019s guidance for undertaking reviews in health care. York: University of York, Centre for Reviews and Dissemination; 2008. http:\/\/www.york.ac.uk\/media\/crd\/Systematic_Reviews.pdf . Accessed 20 Jun 2016."},{"key":"312_CR26","first-page":"S196","volume":"28","author":"CE Ward","year":"2013","unstructured":"Ward CE, Ashburner JM, He W, Atlas SJ. The association between patient experience of care and subsequent cancer prevention and chronic disease outcomes. J Gen Intern Med. 2013;28:S196\u20137.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"312_CR27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0272989X10396717","volume":"31","author":"EM Wever","year":"2011","unstructured":"Wever EM, Draisma G, Heijnsdijk EA, de Koning HJ. How does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening. Med Decis Mak. 2011;31(4):550\u20138.","journal-title":"Med Decis Mak"},{"key":"312_CR28","unstructured":"Surveillance, Epidemiology, and End Results Program, National Cancer Institute. https:\/\/seer.cancer.gov\/tools\/codingmanuals\/historical.html . Accessed 24 Nov 2016."},{"issue":"5","key":"312_CR29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","volume":"32","author":"AH Briggs","year":"2012","unstructured":"Briggs AH, Weinstein MC, Fenwick EA, et al. Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6. Med Decis Mak. 2012;32(5):722\u201332.","journal-title":"Med Decis Mak"},{"issue":"5","key":"312_CR30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/0272989X12454579","volume":"32","author":"DM Eddy","year":"2012","unstructured":"Eddy DM, Hollingworth W, Caro JJ, et al. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Mak. 2012;32(5):733\u201343.","journal-title":"Med Decis Mak"},{"issue":"Suppl. 3","key":"312_CR31","first-page":"38","volume":"16","author":"IO Wong","year":"2010","unstructured":"Wong IO, Kuntz KM, Cowling BJ, et al. Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling. Hong Kong Med J. 2010;16(Suppl. 3):38\u201341.","journal-title":"Hong Kong Med J"},{"issue":"7","key":"312_CR32","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/1097-0142(19901001)66:7<1601::AID-CNCR2820660727>3.0.CO;2-O","volume":"66","author":"GJ Oortmarssen van","year":"1990","unstructured":"van Oortmarssen GJ, Habbema JD, van der Maas PJ, et al. A model for breast cancer screening. Cancer. 1990;66(7):1601\u201312.","journal-title":"Cancer"},{"issue":"11","key":"312_CR33","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/jnci\/djj210","volume":"98","author":"NK Stout","year":"2006","unstructured":"Stout NK, Rosenberg MA, Trentham-Dietz A, et al. Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst. 2006;98(11):774\u201382.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"312_CR34","first-page":"16","volume":"26","author":"N Mittmann","year":"2015","unstructured":"Mittmann N, Stout NK, Lee P, et al. Total cost-effectiveness of mammography screening strategies. Health Rep. 2015;26(12):16\u201325.","journal-title":"Health Rep"},{"key":"312_CR35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jncimonographs\/lgj007","volume":"36","author":"DG Fryback","year":"2006","unstructured":"Fryback DG, Stout NK, Rosenberg MA, et al. The Wisconsin Breast Cancer Epidemiology Simulation Model. J Natl Cancer Inst Monogr. 2006;36:37\u201347.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"312_CR36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1471-2407-11-192","volume":"11","author":"M Carles","year":"2011","unstructured":"Carles M, Vilaprinyo E, Cots F, Gregori A, Pla R, Roman R, et al. Cost-effectiveness of early detection of breast cancer in Catalonia (Spain). BMC Cancer. 2011;11:192.","journal-title":"BMC Cancer"},{"key":"312_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jncimonographs\/lgj011","volume":"36","author":"S Lee","year":"2006","unstructured":"Lee S, Zelen M. A stochastic model for predicting the mortality of breast cancer. J Natl Cancer Inst Monogr. 2006;36:79\u201386.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"312_CR38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2354.2003.00373.x","volume":"12","author":"P Arveux","year":"2003","unstructured":"Arveux P, Wait S, Schaffer P. Building a model to determine the cost-effectiveness of breast cancer screening in France. Eur J Cancer Care. 2003;12(2):143\u201353.","journal-title":"Eur J Cancer Care"},{"issue":"1","key":"312_CR39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00008469-200302000-00012","volume":"12","author":"C Lejeune","year":"2003","unstructured":"Lejeune C, Arveux P, Dancourt V, et al. A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer. Eur J Cancer Prev. 2003;12(1):77\u201384.","journal-title":"Eur J Cancer Prev"},{"issue":"11","key":"312_CR40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jama.1995.03530110043033","volume":"274","author":"KK Lindfors","year":"1995","unstructured":"Lindfors KK, Rosenquist CJ, Lindfors KK, Rosenquist CJ. The cost-effectiveness of mammographic screening strategies [Erratum appears in JAMA. 1996 Jan 10;275(2):112]. JAMA. 1995;274(11):881\u20134.","journal-title":"JAMA"},{"issue":"3","key":"312_CR41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1148\/radiology.191.3.8184041","volume":"191","author":"CJ Rosenquist","year":"1994","unstructured":"Rosenquist CJ, Lindfors KK, Rosenquist CJ, Lindfors KK. Screening mammography in women aged 40\u201349\u00a0years: analysis of cost-effectiveness. Radiology. 1994;191(3):647\u201350.","journal-title":"Radiology"},{"issue":"11","key":"312_CR42","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2235::AID-CNCR19>3.0.CO;2-V","volume":"82","author":"CJ Rosenquist","year":"1998","unstructured":"Rosenquist CJ, Lindfors KK, Rosenquist CJ, Lindfors KK. Screening mammography beginning at age 40\u00a0years: a reappraisal of cost-effectiveness. Cancer. 1998;82(11):2235\u201340.","journal-title":"Cancer"},{"issue":"1","key":"312_CR43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1148\/radiology.190.1.8259408","volume":"190","author":"KK Lindfors","year":"1994","unstructured":"Lindfors KK, Rosenquist CJ. Needle core biopsy guided with mammography: a study of cost-effectiveness. Radiology. 1994;190(1):217\u201322.","journal-title":"Radiology"},{"issue":"1","key":"312_CR44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/eurpub\/7.1.68","volume":"7","author":"R Garuz","year":"1997","unstructured":"Garuz R, Forcen T, Cabases J, et al. Economic evaluation of a mammography-based breast cancer screening programme in Spain. Eur J Public Health. 1997;7(1):68\u201376.","journal-title":"Eur J Public Health"},{"issue":"2","key":"312_CR45","first-page":"161","volume":"27","author":"G Malcolm","year":"1993","unstructured":"Malcolm G. Cost-effectiveness of mammography screening options. N Z Econ Pap. 1993;27(2):161\u201383.","journal-title":"N Z Econ Pap"},{"issue":"6649","key":"312_CR46","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/bmj.297.6649.650","volume":"297","author":"EG Knox","year":"1988","unstructured":"Knox EG, Knox EG. Evaluation of a proposed breast cancer screening regimen. BMJ. 1988;297(6649):650\u20134.","journal-title":"BMJ"},{"issue":"8","key":"312_CR47","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/1097-0142(19910415)67:8<2021::AID-CNCR2820670802>3.0.CO;2-L","volume":"67","author":"I Okubo","year":"1991","unstructured":"Okubo I, Glick H, Frumkin H, et al. Cost-effectiveness analysis of mass screening for breast cancer in Japan. Cancer. 1991;67(8):2021\u20139.","journal-title":"Cancer"},{"key":"312_CR48","doi-asserted-by":"crossref","first-page":"f2618","DOI":"10.1136\/bmj.f2618","volume":"346","author":"PD Pharoah","year":"2013","unstructured":"Pharoah PD, Sewell B, Fitzsimmons D, et al. Cost effectiveness of the NHS breast screening programme: life table model. BMJ. 2013;346:f2618.","journal-title":"BMJ"},{"issue":"8851","key":"312_CR49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0140-6736(93)91067-V","volume":"341","author":"L Nystrom","year":"1993","unstructured":"Nystrom L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993;341(8851):973\u20138.","journal-title":"Lancet"},{"issue":"6654","key":"312_CR50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/bmj.297.6654.943","volume":"297","author":"I Andersson","year":"1988","unstructured":"Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ. 1988;297(6654):943\u20138.","journal-title":"BMJ"},{"issue":"2","key":"312_CR51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jech.43.2.107","volume":"43","author":"L Tabar","year":"1989","unstructured":"Tabar L, Fagerberg G, Duffy SW, Day NE. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Commun Health. 1989;43(2):107\u201314.","journal-title":"J Epidemiol Commun Health"},{"issue":"5","key":"312_CR52","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ijc.2910580502","volume":"58","author":"PM Beemsterboer","year":"1994","unstructured":"Beemsterboer PM, de Koning HJ, Warmerdam PG, et al. Prediction of the effects and costs of breast-cancer screening in Germany. Int J Cancer. 1994;58(5):623\u20138.","journal-title":"Int J Cancer"},{"issue":"3","key":"312_CR53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/eurpub\/8.3.241","volume":"8","author":"PMM Beemsterboer","year":"1998","unstructured":"Beemsterboer PMM, Warmerdam PG, Boer R, et al. Screening for breast cancer in Catalonia: which policy is to be preferred? Eur J Public Health. 1998;8(3):241\u20136.","journal-title":"Eur J Public Health"},{"issue":"12","key":"312_CR54","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/0959-8049(95)00457-2","volume":"31A","author":"R Boer","year":"1995","unstructured":"Boer R, de Koning HJ, van Oortmarssen GJ, van der Maas PJ. In search of the best upper age limit for breast cancer screening. Eur J Cancer. 1995;31A(12):2040\u20133.","journal-title":"Eur J Cancer"},{"issue":"8","key":"312_CR55","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1506::AID-CNCR17>3.0.CO;2-2","volume":"86","author":"R Boer","year":"1999","unstructured":"Boer R, de Koning HJ, van der Maas PJ. A longer breast carcinoma screening interval for women age older than 65\u00a0years? Cancer. 1999;86(8):1506\u201310.","journal-title":"Cancer"},{"key":"312_CR56","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.317.7155.376","volume":"317","author":"R Boer","year":"1998","unstructured":"Boer R, de Koning H, Threlfall A, et al. Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study. BMJ. 1998;317:376\u20139.","journal-title":"BMJ"},{"issue":"1","key":"312_CR57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1753-6405.1993.tb00103.x","volume":"17","author":"R Carter","year":"1993","unstructured":"Carter R, Glasziou P, van Oortmarssen G, et al. Cost-effectiveness of mammographic screening in Australia. Aust J Public Health. 1993;17(1):42\u201350.","journal-title":"Aust J Public Health"},{"issue":"1","key":"312_CR58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2008.09.015","volume":"45","author":"R Gelder de","year":"2009","unstructured":"de Gelder R, Bulliard JL, de Wolf C, et al. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland. Eur J Cancer. 2009;45(1):127\u201338.","journal-title":"Eur J Cancer"},{"issue":"4","key":"312_CR59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ijc.2910490410","volume":"49","author":"HJ Koning de","year":"1991","unstructured":"de Koning HJ, van Ineveld BM, van Oortmarssen GJ, et al. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer. 1991;49(4):531\u20137.","journal-title":"Int J Cancer"},{"issue":"1","key":"312_CR60","first-page":"e5443","volume":"9","author":"S Haghighat","year":"2016","unstructured":"Haghighat S, Akbari ME, Yavari P, et al. Cost-effectiveness of three rounds of mammography breast cancer screening in Iranian women. Iran J Cancer Prev. 2016;9(1):e5443.","journal-title":"Iran J Cancer Prev"},{"key":"312_CR61","unstructured":"BreastScreen Australia Evaluation. Economic evaluation and modelling study prepared by IMS Health Pty Ltd Australia for the Australian Government Department of Health and Ageing. 2009. http:\/\/webarchive.nla.gov.au\/gov\/20090929152622\/http:\/\/www.cancerscreening.gov.au\/internet\/screening\/publishing.nsf\/Content\/br-economic-cnt . Accessed 16 June 2016."},{"issue":"22","key":"312_CR62","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1001\/jama.282.22.2156","volume":"282","author":"K Kerlikowske","year":"1999","unstructured":"Kerlikowske K, Salzmann P, Phillips KA, et al. Continuing screening mammography in women aged 70 to 79\u00a0years: impact on life expectancy and cost-effectiveness. JAMA. 1999;282(22):2156\u201363.","journal-title":"JAMA"},{"issue":"2","key":"312_CR63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1524-4733.2009.00667.x","volume":"13","author":"J Madan","year":"2010","unstructured":"Madan J, Rawdin A, Stevenson M, Tappenden P. A rapid-response economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach. Value Health. 2010;13(2):215\u201321.","journal-title":"Value Health"},{"issue":"13","key":"312_CR64","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1200\/JCO.2004.05.009","volume":"22","author":"JS Mandelblatt","year":"2004","unstructured":"Mandelblatt JS, Schechter CB, Yabroff KR, et al. Benefits and costs of interventions to improve breast cancer outcomes in African American women. J Clin Oncol. 2004;22(13):2554\u201366.","journal-title":"J Clin Oncol"},{"issue":"1","key":"312_CR65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1524-4733.2006.00143.x","volume":"10","author":"K Neeser","year":"2007","unstructured":"Neeser K, Szucs T, Bulliard JL, et al. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors. Value Health. 2007;10(1):42\u201353.","journal-title":"Value Health"},{"issue":"4","key":"312_CR66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jcpo.2014.09.001","volume":"2","author":"R Pataky","year":"2014","unstructured":"Pataky R, Phillips N, Peacock S, Coldman AJ. Cost-effectiveness of population-based mammography screening strategies by age range and frequency. J Cancer Policy. 2014;2(4):97\u2013102.","journal-title":"J Cancer Policy"},{"issue":"6","key":"312_CR67","first-page":"477","volume":"15","author":"G Rennert","year":"1991","unstructured":"Rennert G, Rennert G. The value of mammography in different ethnic groups in Israel: analysis of mortality reduction and costs using CAN*TROL. Cancer Detect Prev. 1991;15(6):477\u201381.","journal-title":"Cancer Detect Prev"},{"issue":"2","key":"312_CR68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1524-4733.2007.00223.x","volume":"11","author":"K Rojnik","year":"2008","unstructured":"Rojnik K, Naversnik K, Mateovic-Rojnik T, Primiczakelj M. Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia. Value Health. 2008;11(2):139\u201348.","journal-title":"Value Health"},{"issue":"11","key":"312_CR69","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-127-11-199712010-00001","volume":"127","author":"P Salzmann","year":"1997","unstructured":"Salzmann P, Kerlikowske K, Phillips K, et al. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49\u00a0years of age.[Erratum appears in Ann Intern Med 1998 May 15;128(10):878]. Ann Intern Med. 1997;127(11):955\u201365.","journal-title":"Ann Intern Med"},{"issue":"8","key":"312_CR70","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/ijc.29572","volume":"137","author":"VD Sankatsing","year":"2015","unstructured":"Sankatsing VD, Heijnsdijk EA, van Luijt PA, et al. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands. Int J Cancer. 2015;137(8):1990\u20139.","journal-title":"Int J Cancer"},{"issue":"2","key":"312_CR71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0168-8510(96)00843-3","volume":"38","author":"KL Szeto","year":"1996","unstructured":"Szeto KL, Devlin NJ, Szeto KL, Devlin NJ. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand. Health Policy. 1996;38(2):101\u201315.","journal-title":"Health Policy"},{"issue":"6","key":"312_CR72","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ijc.2910430617","volume":"43","author":"PJ Maas van der","year":"1989","unstructured":"van der Maas PJ, de Koning HJ, van Ineveld BM, et al. The cost-effectiveness of breast cancer screening. Int J Cancer. 1989;43(6):1055\u201360.","journal-title":"Int J Cancer"},{"issue":"12","key":"312_CR73","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/0959-8049(93)90100-T","volume":"29a","author":"BM Ineveld van","year":"1993","unstructured":"van Ineveld BM, van Oortmarssen GJ, de Koning HJ, et al. How cost-effective is breast cancer screening in different EC countries? Eur J Cancer. 1993;29a(12):1663\u20138.","journal-title":"Eur J Cancer"},{"issue":"4","key":"312_CR74","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/cncr.22848","volume":"110","author":"IO Wong","year":"2007","unstructured":"Wong IO, Kuntz KM, Cowling BJ, et al. Cost effectiveness of mammography screening for Chinese women. Cancer. 2007;110(4):885\u201395.","journal-title":"Cancer"},{"issue":"12","key":"312_CR75","first-page":"3","volume":"26","author":"MJ Yaffe","year":"2015","unstructured":"Yaffe MJ, Mittmann N, Lee P, et al. Modelling mammography screening for breast cancer in the Canadian context: modification and testing of a microsimulation model. Health Rep. 2015;26(12):3\u20138.","journal-title":"Health Rep"},{"key":"312_CR76","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2407-8-331","volume":"8","author":"E Vilaprinyo","year":"2008","unstructured":"Vilaprinyo E, Gispert R, Martinez-Alonso M, et al. Competing risks to breast cancer mortality in Catalonia. BMC Cancer. 2008;8:331.","journal-title":"BMC Cancer"},{"key":"312_CR77","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/1471-2407-8-336","volume":"8","author":"M Rue","year":"2008","unstructured":"Rue M, Carles M, Vilaprinyo E, et al. Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain). BMC Cancer. 2008;8:336.","journal-title":"BMC Cancer"},{"key":"312_CR78","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2407-9-98","volume":"9","author":"E Vilaprinyo","year":"2009","unstructured":"Vilaprinyo E, Rue M, Marcos-Gragera R, Martinez-Alonso M. Estimation of age- and stage-specific Catalan breast cancer survival functions using US and Catalan survival data. BMC Cancer. 2009;9:98.","journal-title":"BMC Cancer"},{"key":"312_CR79","unstructured":"TNM Staging System: American Joint Committee on Cancer (AJCC). Available from https:\/\/cancerstaging.org\/references-tools\/Pages\/What-is-Cancer-Staging.aspx . Accessed 11 Nov 2016."},{"issue":"1","key":"312_CR80","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ijc.29364","volume":"137","author":"R Gelder De","year":"2015","unstructured":"De Gelder R, Heijnsdijk EAM, Fracheboud J, et al. The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy. Int J Cancer. 2015;137(1):165\u201372.","journal-title":"Int J Cancer"},{"issue":"6","key":"312_CR81","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1007\/BF03405630","volume":"103","author":"AJ Coldman","year":"2012","unstructured":"Coldman AJ, Phillips N. False-positive screening mammograms and biopsies among women participating in a Canadian provincial breast screening program. Can J Public Health. 2012;103(6):e420\u20134.","journal-title":"Can J Public Health"},{"issue":"3","key":"312_CR82","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/bjc.2013.732","volume":"110","author":"AJ Coldman","year":"2014","unstructured":"Coldman AJ, Phillips N. Breast cancer survival and prognosis by screening history. Br J Cancer. 2014;110(3):556\u20139.","journal-title":"Br J Cancer"},{"issue":"9855","key":"312_CR83","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","volume":"380","author":"Independent UK Panel on Breast Cancer Screening","year":"2012","unstructured":"Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778\u201386.","journal-title":"Lancet"},{"issue":"4","key":"312_CR84","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.2910490411","volume":"49","author":"JC Haes de","year":"1991","unstructured":"de Haes JC, de Koning HJ, van Oortmarssen GJ, et al. The impact of a breast cancer screening programme on quality-adjusted life-years. Int J Cancer. 1991;49(4):538\u201344.","journal-title":"Int J Cancer"},{"issue":"Suppl. 2","key":"312_CR85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00019053-199600092-00004","volume":"9","author":"J Hutton","year":"1996","unstructured":"Hutton J, Brown R, Borowitz M, et al. A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer. Pharmacoeconomics. 1996;9(Suppl. 2):8\u201322.","journal-title":"Pharmacoeconomics"},{"issue":"22","key":"312_CR86","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1200\/JCO.2005.11.692","volume":"23","author":"JA Hayman","year":"2005","unstructured":"Hayman JA, Kabeto MU, Schipper MJ, et al. Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situ. J Clin Oncol. 2005;23(22):5171\u20137.","journal-title":"J Clin Oncol"},{"issue":"12","key":"312_CR87","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1525-1497.2006.00609.x","volume":"21","author":"MD Schleinitz","year":"2006","unstructured":"Schleinitz MD, DePalo D, Blume J, Stein M. Can differences in breast cancer utilities explain disparities in breast cancer care? J Gen Intern Med. 2006;21(12):1253\u201360.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"312_CR88","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11136-008-9353-2","volume":"17","author":"AE Bonomi","year":"2008","unstructured":"Bonomi AE, Boudreau DM, Fishman PA, et al. Quality of life valuations of mammography screening. Qual Life Res. 2008;17(5):801\u201314.","journal-title":"Qual Life Res"},{"key":"312_CR89","volume-title":"UK population norms for EQ-5D: discussion paper series","author":"P Kind","year":"1999","unstructured":"Kind P, Hardman G, Macran S. UK population norms for EQ-5D: discussion paper series. York: University of York, Centre for Health Economics; 1999."},{"issue":"5","key":"312_CR90","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/erp.10.65","volume":"10","author":"T Peasgood","year":"2010","unstructured":"Peasgood T, Ward SE, Brazier J. Health-state utility values in breast cancer. J Expert Rev Pharmacoecon Outcomes Res. 2010;10(5):553\u201366.","journal-title":"J Expert Rev Pharmacoecon Outcomes Res"},{"issue":"8","key":"312_CR91","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/A:1008230000822","volume":"8","author":"G Liljegren","year":"1997","unstructured":"Liljegren G, Karlsson G, Bergh J, Holmberg L. The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I: results from a randomized trial. Ann Oncol. 1997;8(8):757\u201363.","journal-title":"Ann Oncol"},{"issue":"9","key":"312_CR92","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0277-9536(92)90130-I","volume":"34","author":"J Hall","year":"1992","unstructured":"Hall J, Gerard K, Salkeld G, Richardson J. A cost utility analysis of mammography screening in Australia. Soc Sci Med. 1992;34(9):993\u20131004.","journal-title":"Soc Sci Med"},{"key":"312_CR93","unstructured":"Street AD, Posnett J, Threlfall AG, et al. Economic evaluation of proposed changes to the breast screening programme. Report P20\/03. York: York Health Economics Consortium, University of York; 1996."},{"issue":"8388","key":"312_CR94","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(84)91703-3","volume":"1","author":"AL Verbeek","year":"1984","unstructured":"Verbeek AL, Hendriks JH, Holland R, et al. Reduction of breast cancer mortality through mass screening with modern mammography: first results of the Nijmegen Project, 1975\u20131981. Lancet. 1984;1(8388):1222\u20134.","journal-title":"Lancet"},{"issue":"8388","key":"312_CR95","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0140-6736(84)91704-5","volume":"1","author":"HJ Collette","year":"1984","unstructured":"Collette HJ, Day NE, Rombach JJ, de Waard F. Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet. 1984;1(8388):1224\u20136.","journal-title":"Lancet"},{"issue":"8433","key":"312_CR96","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(85)92204-4","volume":"1","author":"L Tabar","year":"1985","unstructured":"Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985;1(8433):829\u201332.","journal-title":"Lancet"},{"issue":"16","key":"312_CR97","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/jnci\/87.16.1217","volume":"87","author":"HJ Koning de","year":"1995","unstructured":"de Koning HJ, Boer R, Warmerdam PG, et al. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst. 1995;87(16):1217\u201323.","journal-title":"J Natl Cancer Inst"},{"key":"312_CR98","unstructured":"National Evaluation Team for Breast Cancer Screening. National evaluation of breast cancer screening in the Netherlands 1990\u20132011\/2012. 13th evaluation report. Rotterdam: Erasmus MC University Medical Center Rotterdam, Radboud University Nijmegen Medical Centre; 2014."},{"issue":"16","key":"312_CR99","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.ejca.2013.06.020","volume":"49","author":"PA Luijt van","year":"2013","unstructured":"van Luijt PA, Fracheboud J, Heijnsdijk EA, et al. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens. Eur J Cancer. 2013;49(16):3517\u201325.","journal-title":"Eur J Cancer"},{"issue":"9552","key":"312_CR100","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(06)69834-6","volume":"368","author":"SM Moss","year":"2006","unstructured":"Moss SM, Cuckle H, Evans A, et al. Effect of mammographic screening from age 40\u00a0years on breast cancer mortality at 10\u00a0years\u2019 follow-up: a randomised controlled trial. Lancet. 2006;368(9552):2053\u201360.","journal-title":"Lancet"},{"issue":"8684","key":"312_CR101","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0140-6736(90)90066-E","volume":"335","author":"MM Roberts","year":"1990","unstructured":"Roberts MM, Alexander FE, Anderson TJ, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet. 1990;335(8684):241\u20136.","journal-title":"Lancet"},{"issue":"9168","key":"312_CR102","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(98)07413-3","volume":"353","author":"FE Alexander","year":"1999","unstructured":"Alexander FE, Anderson TJ, Brown HK, et al. 14\u00a0years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet. 1999;353(9168):1903\u20138.","journal-title":"Lancet"},{"key":"312_CR103","volume-title":"Periodic screening for breast cancer: the Health Insurance Plan Project and its sequelae, 1963\u20131986","author":"S Shapiro","year":"1988","unstructured":"Shapiro S, Venet W, Strax P. Periodic screening for breast cancer: the Health Insurance Plan Project and its sequelae, 1963\u20131986. Baltimore: Johns Hopkins University Press; 1988."},{"issue":"9310","key":"312_CR104","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","volume":"359","author":"L Nystrom","year":"2002","unstructured":"Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359(9310):909\u201319.","journal-title":"Lancet"},{"issue":"10","key":"312_CR105","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-151-10-200911170-00010","volume":"151","author":"JS Mandelblatt","year":"2009","unstructured":"Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738\u201347.","journal-title":"Ann Intern Med"},{"issue":"5","key":"312_CR106","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0272989X12455463","volume":"32","author":"U Siebert","year":"2012","unstructured":"Siebert U, Alagoz O, Bayoumi AM, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Mak. 2012;32(5):690\u2013700.","journal-title":"Med Decis Mak"},{"issue":"4","key":"312_CR107","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/pubmed\/fdg075","volume":"25","author":"D Fone","year":"2003","unstructured":"Fone D, Hollinghurst S, Temple M, et al. Systematic review of the use and value of computer simulation modelling in population health and health care delivery. J Public Health Med. 2003;25(4):325\u201335.","journal-title":"J Public Health Med"},{"key":"312_CR108","doi-asserted-by":"crossref","unstructured":"Trikalinos TA, Siebert U, Lau J. AHRQ methods for effective health care, decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations. Medical tests: White Paper series. Rockville: Agency for Healthcare Research and Quality; 2009.","DOI":"10.1177\/0272989X09345022"},{"key":"312_CR109","unstructured":"Shepard DS. Cost-effectiveness in health and medicine. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. New York: Oxford University Press; 1996. J Ment Health Policy Econ. 1999;2(2):91\u20132."},{"issue":"4","key":"312_CR110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40273-015-0327-2","volume":"34","author":"P Vemer","year":"2016","unstructured":"Vemer P, Corro Ramos I, van Voorn GA, et al. AdViSHE: a validation-assessment tool of health-economic models for decision makers and model users. Pharmacoeconomics. 2016;34(4):349\u201361.","journal-title":"Pharmacoeconomics"},{"key":"312_CR111","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jncimonographs\/lgj015","volume":"36","author":"KA Cronin","year":"2006","unstructured":"Cronin KA, Feuer EJ, Clarke LD, Plevritis SK. Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis. J Natl Cancer Inst Monogr. 2006;36:112\u201321.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"312_CR112","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","volume":"97","author":"B Erbas","year":"2006","unstructured":"Erbas B, Provenzano E, Armes J, Gertig D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat. 2006;97(2):135\u201344.","journal-title":"Breast Cancer Res Treat"},{"issue":"20","key":"312_CR113","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jnci\/94.20.1546","volume":"94","author":"VL Ernster","year":"2002","unstructured":"Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546\u201354.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"312_CR114","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jnci\/82.19.1546","volume":"82","author":"E White","year":"1990","unstructured":"White E, Lee CY, Kristal AR. Evaluation of the increase in breast cancer incidence in relation to mammography use. J Nat Cancer Inst. 1990;82(19):1546\u201352.","journal-title":"J Nat Cancer Inst"},{"issue":"14","key":"312_CR115","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMra031301","volume":"350","author":"HJ Burstein","year":"2004","unstructured":"Burstein HJ, Polyak K, Wong JS, et al. Ductal carcinoma in situ of the breast. N Engl J Med. 2004;350(14):1430\u201341.","journal-title":"N Engl J Med"},{"key":"312_CR116","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/epirev\/mxr009","volume":"33","author":"R Gelder de","year":"2011","unstructured":"de Gelder R, Heijnsdijk EA, van Ravesteyn NT, et al. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev. 2011;33:111\u201321.","journal-title":"Epidemiol Rev"},{"issue":"3","key":"312_CR117","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","volume":"102","author":"BA Virnig","year":"2010","unstructured":"Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"312_CR118","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/biomet\/56.3.601","volume":"56","author":"M Zelen","year":"1969","unstructured":"Zelen M, Feinleib M. On the theory of screening of chronic diseases. Biometrika. 1969;56(3):601\u201314.","journal-title":"Biometrika"},{"key":"312_CR119","doi-asserted-by":"crossref","unstructured":"Brennan VK, Wolowacz SE. A systematic review of breast cancer utility weights. In: Poster presentation at the International Society for Pharmacoeconomics and Outcomes Research 13th annual international meeting; Toronto, Canada, 2008.","DOI":"10.1016\/S1098-3015(10)70253-9"},{"issue":"1","key":"312_CR120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1523-5394.1999.07103.x","volume":"7","author":"DW Brown","year":"1999","unstructured":"Brown DW, French MT, Schweitzer ME, et al. Economic evaluation of breast cancer screening: a review. Cancer Pract. 1999;7(1):28\u201333.","journal-title":"Cancer Pract"},{"issue":"3","key":"312_CR121","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00019053-200826030-00004","volume":"26","author":"SY Kim","year":"2008","unstructured":"Kim SY, Goldie SJ. Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches. Pharmacoeconomics. 2008;26(3):191\u2013215.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"312_CR122","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00005650-200205000-00004","volume":"40","author":"F Sassi","year":"2002","unstructured":"Sassi F, Archard L, McDaid D. Searching literature databases for health care economic evaluations: how systematic can we afford to be? Med Care. 2002;40(5):387\u201394.","journal-title":"Med Care"},{"key":"312_CR123","first-page":"MR000010","volume":"2","author":"S Hopewell","year":"2007","unstructured":"Hopewell S, McDonald S, Clarke M, Egger M. Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst Rev. 2007;2:MR000010.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-017-0312-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40258-017-0312-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-017-0312-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T09:58:22Z","timestamp":1568800702000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40258-017-0312-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":123,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1007\/s40258-017-0312-3","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,10]]}}}